Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 3Completed 2Terminated 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 76NIH 16NETWORK 13INDUSTRY 8OTHER_GOV 3

Study Type

Observational 7Interventional 1

Sponsor

Cancer Type

Thoracic 3Genitourinary 2Other hematologic neoplasm 1Gastrointestinal 1Dermatologic 1

Conditions

Prostatic Neoplasms 2Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Trauma, Nervous System 1Thoracic Injuries 1Small Cell Lung Carcinoma 1Radiculopathy 1Pneumonia 1Pathologic Complete Response 1Melanoma 1Lung Diseases, Interstitial 1Leukemia, Myeloid, Acute 1Klippel-Feil Syndrome 1Intervertebral Disc Degeneration 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 604Carboplatin 371Paclitaxel 283Cisplatin 266Gemcitabine 255Pemetrexed 195Bevacizumab 192Nivolumab 191Docetaxel 189Injections 166Cyclophosphamide 145atezolizumab 137Capecitabine 135Fluorouracil 133Oxaliplatin 132Dexamethasone 129durvalumab 114Fulvestrant 114130-nm albumin-bound paclitaxel 109Cetuximab 100fludarabine 99Rituximab 97Leucovorin 95venetoclax 88Lenalidomide 84Prednisone 78enzalutamide 77Azacitidine 75Ipilimumab 74Irinotecan 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
INDUSTRY × Observation × 1 year × Clear all
NCT06192004 2026-05-04

LOOP

AstraZeneca

Terminated
83 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pneumonia, Lung Diseases, Interstitial

NCT05257551 2026-04-02

TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)

Tempus AI

Recruiting
200 enrolled
Thoracic

Neoplasms, Small Cell Lung Carcinoma

NCT05236114 2026-02-05

GEMINI-NSCLC: NSCLC Biomarker Study

Tempus AI

Recruiting
1,200 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT06887348 2026-01-12

RPx

Replimune, Inc.

Recruiting
50 enrolled
DermatologicGastrointestinal

Carcinoma, Hepatocellular, Melanoma

NCT04770571 2025-12-22

Posterior Cervical Fixation Study

Globus Medical Inc

Enrolling by invitation
150 enrolled

Klippel-Feil Syndrome, Radiculopathy, Thoracic Injuries, Trauma, Nervous System, Intervertebral Disc Degeneration

NCT04229979 2025-10-01

REGAL

Sellas Life Sciences Group

Phase 3 Active not recruiting
127 enrolled
Other hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Acute

NCT05323747 2025-09-16

BP-008

BioProtect

Completed
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT05354427 2025-09-16

CLP-10095

BioProtect

Completed
175 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡